v3.24.1.1.u2
Share-Based Compensation (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Shares Available for Grant 2,400    
Share-based compensation expense $ 45,647 $ 50,978 $ 63,067
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Deferred income tax benefit 11,000 $ 12,500 15,200
Unrecognized compensation expense $ 69,500    
Weighted average period unrecognized compensation expense expected to be recognized 1 year 6 months    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 417 206  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 124.59    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 94.03    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 316    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 0 $ 190.75  
Issuance of shares upon the exercise of stock appreciation rights (in shares) 0 (3)  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price $ 162.54    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period (104)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $ 529    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 8 years 8 months 12 days    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value $ 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 186.22    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 80    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 28.97    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 6 years 10 months 24 days    
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation expense $ 6,400 $ 11,800 $ 22,800
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested, beginning of period 105    
Granted 22 0  
Granted, Weighted Average Grant Date Fair Value $ 135.13 $ 0 $ 0
Change in Units Based on Performance (15)    
Change in Units Based on Performance, Weighted Average Exercise Price $ 137.11    
Vested (112)    
Vested, Weighted Average Exercise Price $ 130.88    
Forfeited 0    
Forfeited, Weighted Average Grant Date Fair Value $ 130.03    
Nonvested, end of period 0 105  
Nonvested, Weighted Average Grant Date Fair Value $ 0 $ 130.88  
Maximum potential payout of outstanding awards for Equity Instruments Other than Options 44    
Total grant date fair value of vested $ 14,711 $ 12,460 $ 7,987
Market Based Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate (1) 4.60% 1.60% 0.30%
Expected dividend yield 0.00% 0.00% 0.00%
Expected stock price volatility (2) 37.40% 34.60% 36.00%
Liquidity discount for post-vest restrictions 12.20%    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested, beginning of period 135    
Granted 73    
Granted, Weighted Average Grant Date Fair Value $ 139.75 $ 205.52 $ 204.97
Change in Units Based on Performance 0    
Change in Units Based on Performance, Weighted Average Exercise Price $ 0    
Vested (30)    
Vested, Weighted Average Exercise Price $ 145.04    
Forfeited (55)    
Forfeited, Weighted Average Grant Date Fair Value $ 173.13    
Nonvested, end of period 123 135  
Nonvested, Weighted Average Grant Date Fair Value $ 180.63 $ 191.72  
Maximum potential payout of outstanding awards for Equity Instruments Other than Options   255  
Total grant date fair value of vested $ 4,400 $ 3,695 $ 3,650
Deferred Stock Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation expense $ 3,400 $ 1,700 $ 1,600
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Granted 74 9,000 10,000
Granted, Weighted Average Grant Date Fair Value $ 66.60 $ 193.05 $ 191.24
Employee Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Shares Available for Grant 2,500    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Purchase discount of fair market value (percent) 10.00%    
Team Member annual purchase limit $ 25    
Team Member annual purchase limit, percentage of compensation (percent) 10.00%    
Share-based Payment Arrangement, Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Expected life of awards (in months) (3) 6 years    
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested, beginning of period 394    
Granted 627    
Granted, Weighted Average Grant Date Fair Value $ 89.81 $ 196.61 $ 183.41
Change in Units Based on Performance 0    
Change in Units Based on Performance, Weighted Average Exercise Price $ 0    
Vested (195)    
Vested, Weighted Average Exercise Price $ 169.61    
Forfeited (126)    
Forfeited, Weighted Average Grant Date Fair Value $ 139.70    
Nonvested, end of period 700 394  
Nonvested, Weighted Average Grant Date Fair Value $ 109.56 $ 180.41  
Total grant date fair value of vested $ 33,125 $ 34,685 $ 34,555
Minimum | Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Typical number of awards vesting at end of period (percent) 0.00%    
Minimum | Share-based Payment Arrangement, Option      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate (1) 4.08%    
Expected dividend yield 1.45%    
Expected stock price volatility (2) 35.10%    
Maximum | Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Typical number of awards vesting at end of period (percent) 200.00%    
Maximum | Share-based Payment Arrangement, Option      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate (1) 4.31%    
Expected dividend yield 4.05%    
Expected stock price volatility (2) 42.90%